First-in-human study of ELU001, a targeted nanoparticle drug conjugate, in subjects with folate receptor α (FRα) overexpressing solid tumors Meeting Abstract
| Authors: | Ma, W. W.; Orr, D.; Perez, C. A.; Murciano-Goroff, Y. R.; Hamilton, E. P.; Zhao, Y.; Anders, C.; Adams, G. P.; Reddick, C.; McClintock, H. W.; Bayever, E.; Tolcher, A. W. |
| Abstract Title: | First-in-human study of ELU001, a targeted nanoparticle drug conjugate, in subjects with folate receptor α (FRα) overexpressing solid tumors |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S482 |
| End Page: | S483 |
| Language: | English |
| ACCESSION: | WOS:001087480201034 |
| DOI: | 10.1016/j.annonc.2023.09.1878 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 692P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
